This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
OECD/WHO. “Mortality from Cardiovascular Disease”, in Health at a Glance: Asia/Pacific 2012: OECD Publishing. [online] 2012. [cited 2014 Feb 28]; Available from: http://dx.doi.org/10.1787/9789264183902-8-enOECD/WHO“Mortality from Cardiovascular Disease”, in Health at a Glance: Asia/Pacific 2012: OECD Publishing2012[cited 2014 Feb 28]; Available fromhttp://dx.doi.org/10.1787/9789264183902-8-en10.1787/9789264183902-8-enSearch in Google Scholar
Kromhaut D, Bosschieter E, de Lezenne Coutander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985; 312:1205-9.10.1056/NEJM1985050931219013990713KromhautDBosschieterEde Lezenne CoutanderC.The inverse relation between fish consumption and 20-year mortality from coronary heart diseaseN Engl J Med.198531212059Open DOISearch in Google Scholar
Singh R, Niaz M, Sharma J, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebocontrolled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: The Indian Experiment of Infarct Survival. Cardiovasc Drug Ther. 1997; 11:485-91.10.1023/A:1007757724505SinghRNiazMSharmaJKumarRRastogiVMoshiriM.Randomized, double-blind, placebocontrolled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: The Indian Experiment of Infarct SurvivalCardiovasc Drug Ther.19971148591Open DOISearch in Google Scholar
Albert C, Hennekens C, O’Donnell C, Ajani U, Carey V, Willet W, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998; 279:23-8.942403910.1001/jama.279.1.23AlbertCHennekensCO’DonnellCAjaniUCareyVWilletWFish consumption and risk of sudden cardiac deathJAMA.1998279238Search in Google Scholar
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial [errata in Lancet 2001;357:642 and Lancet 2007;369:106]. Lancet. 1999; 354:447-55.GISSI-Prevenzione InvestigatorsDietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial [errata in Lancet 2001;357:642 and Lancet 2007;369:106]. Lancet.199935444755Search in Google Scholar
Burr M, Gilbert J, Holliday R, Elwood P, Fehily A, Rogers S, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet. 1989; 2: 757-61.2571009BurrMGilbertJHollidayRElwoodPFehilyARogersSEffects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART)Lancet.198927576110.1016/S0140-6736(89)90828-3Search in Google Scholar
Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, et al. OMEGA, a randomized, placebocontrolled trial to test the effect of highly purified omega-3 fatty acids on top of modern guidelineadjusted therapy after myocardial infarction. Circulation. 2010; 122:2152-9.10.1161/CIRCULATIONAHA.110.948562RauchBSchieleRSchneiderSDillerFVictorNGohlkeHOMEGA, a randomized, placebocontrolled trial to test the effect of highly purified omega-3 fatty acids on top of modern guidelineadjusted therapy after myocardial infarctionCirculation.20101222152921060071Open DOISearch in Google Scholar
The ORIGIN Trial Investigators. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012; 367:309-18.22686415The ORIGIN Trial Investigators. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemiaN Engl J Med.20123673091810.1056/NEJMoa120385922686415Search in Google Scholar
Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S, et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ. 2010; 341: c6273.2111558910.1136/bmj.c6273GalanPKesse-GuyotECzernichowSBrianconSBlacherJHercbergSEffects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trialBMJ.2010341c6273299304521115589Search in Google Scholar
Kromhout D, Giltay E, Geleijnse J, for the Alpha Omega Trial Group. N-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010; 363:2015-26.2092934110.1056/NEJMoa1003603KromhoutDGiltayEGeleijnse, J for the Alpha Omega Trial Group. N-3 fatty acids and cardiovascular events after myocardial infarctionN Engl J Med.201036320152620929341Search in Google Scholar
Hooper L, Harrison R, Summerbell C, Moore H, Worthington H, Ness A, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease (review). Cochrane Database Syst Rev. 2009; CD003177.HooperLHarrisonRSummerbellCMooreHWorthingtonHNessAOmega 3 fatty acids for prevention and treatment of cardiovascular disease (review)Cochrane Database Syst Rev.2009CD003177Search in Google Scholar
Rizos E, Ntzani E, Bika E, Kostapanos M, Elisaf M. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012; 308:1024-33.10.1001/2012.jama.1137422968891RizosENtzaniEBikaEKostapanosMElisafM.Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysisJAMA.201230810243322968891Open DOISearch in Google Scholar
Marik P, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009; 32:365-72.1960989110.1002/clc.20604MarikPVaronJ.Omega-3 dietary supplements and the risk of cardiovascular events: a systematic reviewClin Cardiol.20093236572Search in Google Scholar
Bucher H, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002; 112:298-304.10.1016/S0002-9343(01)01114-711893369BucherHHengstlerPSchindlerCMeierG.N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trialsAm J Med.2002112298304Open DOISearch in Google Scholar
Leon H, Shibata M, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki R. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2009; 338: a2931.LeonHShibataMSivakumaranSDorganMChatterleyTTsuyukiR.Effect of fish oil on arrhythmias and mortality: systematic reviewBMJ2009338a293110.1136/bmj.a2931Search in Google Scholar
Kwak S, Myung S, Lee Y, Seo H, for the Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease. Arch Intern Med. 2012; 172:686-94.10.1001/archinternmed.2012.262KwakSMyungSLeeYSeoHfor the Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular diseaseArch Intern Med.201217268694Open DOISearch in Google Scholar
Mozaffarian D, Rimm E. Fish intake, contaminants, and human health evaluating the risks and the benefits. JAMA. 2006; 296:1885-99.1704721910.1001/jama.296.15.1885MozaffarianDRimmE.Fish intake, contaminants, and human health evaluating the risks and the benefitsJAMA.2006296188599Search in Google Scholar
Marchioli R, Schweigerb C, Tavazzi L, Valagussad F. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Lipids. 2001; 36(Suppl.):S119-26.11837985MarchioliRSchweigerbCTavazziLValagussadF.Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trialLipids200136SupplS1192610.1007/s11745-001-0694-8Search in Google Scholar
GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebocontrolled trial. Lancet. 2008; 372:1223-30.GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebocontrolled trialLancet.200837212233010.1016/S0140-6736(08)61239-8Search in Google Scholar
Report of Consumer Price Index of Thailand Year 2003-2013 (BASE YEAR 2011): Bureau of Trade and Economic Indices, Ministry of Commerce. [online] 2013. [cited 2013 Nov 27]; Available from: http://www.indexpr.moc.go.th/price_present/TableIndexG_region.asp?table_name=cpig_index_country&province_code=&type_code=g&check_f=i&year_base=2554&nyear=2546Report of Consumer Price Index of Thailand Year 2003-2013 (BASE YEAR 2011): Bureau of Trade and Economic Indices, Ministry of Commerce[online]2013[cited 2013 Nov 27]http://www.indexpr.moc.go.th/price_present/TableIndexG_region.asp?table_name=cpig_index_country&province_code=&type_code=g&check_f=i&year_base=2554&nyear=2546Search in Google Scholar
Anukoolsawat P, Sritara P, Teerawattananon Y. Costs of lifetime treatment of acute coronary syndrome at Ramathibodi Hospital. Thai Heart J. 2006; 19:132-43.AnukoolsawatPSritaraPTeerawattananonY.Costs of lifetime treatment of acute coronary syndrome at Ramathibodi HospitalThai Heart J.20061913243Search in Google Scholar
Khiaocharoen O, Pannarunothai S, Riewpaiboon W, Ingsrisawang L, Teerawattananon Y. Economic evaluation of rehabilitation services for inpatients with stroke in Thailand: a prospective cohort study. Value Health Region Issues. 2012; 1:29-35.10.1016/j.vhri.2012.03.021KhiaocharoenOPannarunothaiSRiewpaiboonWIngsrisawangLTeerawattananonY.Economic evaluation of rehabilitation services for inpatients with stroke in Thailand: a prospective cohort studyValue Health Region Issues.20121293529702822Open DOISearch in Google Scholar
Tsevat J, Goldman L, Soukup J, Lamas G, Connors K, Chapin C, et al. Stability of time-tradeoff utilities in survivors of myocardial infarction. Med Decis Making. 1993; 13:161-5.848340110.1177/0272989X9301300210TsevatJGoldmanLSoukupJLamasGConnorsKChapinCStability of time-tradeoff utilities in survivors of myocardial infarctionMed Decis Making.19931316158483401Search in Google Scholar
Wannasiri Y, Kapol N. The health utility of stroke patients at Ratchaburi Hospital (in Thai). Region 4-5 Med J. 2010; 29:95-103.WannasiriYKapolN.The health utility of stroke patients at Ratchaburi Hospital (in Thai)Region 4-5 Med J.20102995103Search in Google Scholar
Liew D, De Abreu Lourenco R, Adena M, Chim L, Aylward P. Cost-effectiveness of 12-month treatment with ticagrelor compared with clopidogrel in the management of acute coronary syndromes. Clin Ther. 2013; 35:1110-7.2389136110.1016/j.clinthera.2013.06.015LiewDDe Abreu LourencoRAdenaMChimLAylwardP.Cost-effectiveness of 12-month treatment with ticagrelor compared with clopidogrel in the management of acute coronary syndromesClin Ther.2013351110723891361Search in Google Scholar
Calvert M, Freemantle N, Cleland J. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail. 2005; 7:243-51.1570147410.1016/j.ejheart.2005.01.012CalvertMFreemantleNClelandJ.The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF studyEur J Heart Fail.200572435115701474Search in Google Scholar
Kraai I, Vermeulen K, Luttik M, Hoekstra T, Jaarsma T, Hillege H. Preferences of heart failure patients in daily clinical practice: quality of life or longevity. Eur J Heart Fail. 2013; 15:1113-21.2365013010.1093/eurjhf/hft071KraaiIVermeulenKLuttikMHoekstraTJaarsmaTHillegeH.Preferences of heart failure patients in daily clinical practice: quality of life or longevityEur J Heart Fail.20131511132123650130Search in Google Scholar
Limwattananon S. Sensitivity analysis for uncertainty variables used in the model. In: Chaikletkaow U, Teerawattananon Y, editors. Guideline of Health Technology Assessment for Thailand. 2. Bangkok: Chulalongkorn University Book Center; 2013. p. 105-8.LimwattananonS.Sensitivity analysis for uncertainty variables used in the modelChaikletkaowUTeerawattananonYGuideline of Health Technology Assessment for Thailand. 2BangkokChulalongkorn University Book Center20131058Search in Google Scholar
Gerlier L, Vellopoulou K, Lamotte M, Lacey L, Einroos A, Carr E. A health economic evaluation of omega-3 acid ethyl esters 90 in the secondary prevention post-MI in Ireland and Estonia. Abstract presented in ISPOR 15th Annual European Congress. 2012; 15:A373.GerlierLVellopoulouKLamotteMLaceyLEinroosACarrE.A health economic evaluation of omega-3 acid ethyl esters 90 in the secondary prevention post-MI in Ireland and EstoniaAbstract presented in ISPOR 15th Annual European Congress201215A37310.1016/j.jval.2012.08.1008Search in Google Scholar
Quilici S, Martin M, McGuire A, Zoellner Y. A costeffective analysis of n-3 PUFA (Omacor) treatment in post-MI patients. J Clin Prac. 2006; 60:922-32.10.1111/j.1742-1241.2006.01009.xQuiliciSMartinMMcGuireAZoellnerY.A costeffective analysis of n-3 PUFA (Omacor) treatment in post-MI patientsJ Clin Prac.2006609223216893435Open DOISearch in Google Scholar
Lamotte M, Annemans L, Kawalec P, Zoellner Y. A multi-country health economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeconomics. 2006; 24:783-95.10.2165/00019053-200624080-0000516898848LamotteMAnnemansLKawalecPZoellnerY.A multi-country health economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in secondary prevention after myocardial infarctionPharmacoeconomics.2006247839516898848Open DOISearch in Google Scholar
